Why the study?
Up to 40% of burn patients develop ARDS with hypoxia that may fail to respond to conventional therapy and ventilatory management, and literature on using ECMO in burn patients with ARDS is limited.
Answers are grounded in this paper and cite their sources.
This case report demonstrates that extracorporeal membrane oxygenation (ECMO) can be used with a favourable outcome in a burn patient suffering from severe ARDS and resistant hypoxia due to Klebsiella pneumoniae pneumonia.
Burn injuries are common and carry high morbidity and mortality. Up to 40% of burn patients develop acute respiratory distress syndrome (ARDS) due to inhalational injury or infective pneumonia, and hypoxia may fail to respond to conventional therapy and ventilatory management. In this life-threatening scenario, extracorporeal membrane oxygenation (ECMO) therapy can be lifesaving, though literature on its use in burn patients with ARDS is limited. We report a case of Klebsiella pneumoniae pneumonia complicating into ARDS in a burn patient with resistant hypoxia, requiring ECMO therapy, with a favourable outcome.
No takes yet. Share an insight, caveat, or question.
Suliman et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: